Compare PRMB & ICLR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PRMB | ICLR |
|---|---|---|
| Founded | 1955 | 1990 |
| Country | United States | Ireland |
| Employees | 12000 | N/A |
| Industry | | Biotechnology: Commercial Physical & Biological Resarch |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.8B | 9.3B |
| IPO Year | N/A | 2001 |
| Metric | PRMB | ICLR |
|---|---|---|
| Price | $22.70 | $165.76 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 9 | 13 |
| Target Price | $24.00 | ★ $178.62 |
| AVG Volume (30 Days) | ★ 2.7M | 785.7K |
| Earning Date | 05-07-2026 | 05-12-2026 |
| Dividend Yield | ★ 2.49% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $2.34 | N/A |
| Revenue Next Year | $3.56 | N/A |
| P/E Ratio | ★ N/A | $12.91 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $14.36 | $66.57 |
| 52 Week High | $29.00 | $203.91 |
| Indicator | PRMB | ICLR |
|---|---|---|
| Relative Strength Index (RSI) | 38.60 | 57.24 |
| Support Level | $21.74 | $162.06 |
| Resistance Level | $22.96 | $191.33 |
| Average True Range (ATR) | 0.75 | 5.88 |
| MACD | -0.25 | -1.50 |
| Stochastic Oscillator | 5.21 | 25.97 |
Primo Brands Corp is a North American branded beverage company focused on healthy hydration. It delivers sustainably and domestically sourced diversified offerings across products, formats, channels, price points, and consumer occasions, distributed in every state and Canada. Primo Brands is in reusable packaging, helping to reduce waste through its reusable, multi-serve bottles and brand packaging portfolio, which includes recycled plastic, aluminum, and glass.
Icon is a global contract research organization that provides outsourced clinical development services to pharmaceutical and biotechnology firms. Icon supports clients across late-stage clinical trials through the regulatory approval process and postmarket studies. Icon's services include clinical trial management, patient recruitment, data analytics, laboratory services, and regulatory consulting. With more than 40,000 employees operating in over 50 countries, the company partners with life sciences firms to run clinical trials and bring new drugs to market.